Skip to main content
SpringerLink
Log in

Diabetes mellitus and risk of prostate cancer (United States)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

A lower risk of prostate cancer among diabetics has been suggested by several but not all studies. However, the studies have not always accounted for time since diagnosis of diabetes mellitus, or have not examined confounding factors such as diet and diagnostic bias. We thus examined this relationship in the Health Professionals Follow-Up Study from 1986 and 1994, in which 1,369 new cases of non-stage A1 prostate cancer were documented in 47,781 men. A prior history of a diagnosis of diabetes (mostly adult-onset) was associated with a reduced risk of prostate cancer (multivariate relative risk [RR] = 0.75; 95 percent confidence interval [CI] = 0.59-0.95) controlling for age, body mass index (wt/ht2) at age 21, and, in 1986, race, vasectomy, and intakes of total energy, total fat, calcium, fructose, and lycopene. After excluding the first year of follow-up after the diagnosis of diabetes, the RR was 0.63 (CI = 0.54-0.89). Prostate cancer was not reduced in the first five years after diagnosis (RR = 1.24, CI = 0.87-1.77), but was lower in the next five years (RR = 0.66, CI = 0.39-1.10) and lowest after 10 years (RR = 0.54, CI = 0.37-0.78); P-value for trend across time = 0.004. Similar associations were noted for advanced cases. Detection bias was unlikely to account for our findings. The basis of this relationship is unclear but may reflect hormonal changes related to diabetes, perhaps low testosterone levels.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Henderson BE, Bogdanoff E, Gerkins VR, SooHoo J, Arthur M. Evaluation of cancer risk factors in a retirement community. Cancer Res1974; 34: 1045–8.

    Google Scholar 

  2. Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL. Heart disease risk factors, diabetes, and prostatic cancer in an adult community. Am J Epidemiol1989; 129: 511–7.

    Google Scholar 

  3. La Vecchia C, Negri E, Franceschi S, D'Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer1994; 70: 950–3.

    Google Scholar 

  4. Adami HO, McLaughlin J, Ekbom A, et al.Cancer risk in patients with diabetes mellitus. Cancer Causes Control1991; 2: 307–14.

    Google Scholar 

  5. Kessler II. Cancer mortality among diabetics. JNatl Cancer Inst1970; 44: 673–86.

    Google Scholar 

  6. Ragozzino M, Melton JM III, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis1982; 35: 13–9.

    Google Scholar 

  7. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis1985; 38: 435–41.

    Google Scholar 

  8. Bach LA, Rechler MM. Insulin-like growth factors and diabetes. Diabetes Metab Rev1992; 8: 229–57.

    Google Scholar 

  9. Ando S, Rubens R, Rottiers R. Androgen plasma levels in male diabetics. J Endocrinol Invest1984; 7: 21–4.

    Google Scholar 

  10. Barrett-Connor E, Khaw KT, Yen SSC. Endogenous sex hormone levels in older adult men with diabetes mellitus. Am J Epidemiol1990; 132: 895–901.

    Google Scholar 

  11. Shahwan MM, Spathis GS, Fry DE, Wood PJ, Marks V. Differences in pituitary and testicular function between diabetic patients on insulin and oral anti-diabetic agents. Diabetologia1978; 15: 13–7.

    Google Scholar 

  12. Fushimi H, Horie H, Inoue T, et al.Low testosterone levels in diabetic men and animals: a possible role in testicular impotence. Diabetes Res Clin Pract1989; 6: 297–301.

    Google Scholar 

  13. Madsbad S, Gluud C, Bennett P, Krarup T. Rapid changes in plasma androgens during insulin withdrawal in male type 1 (insulin-dependent) diabetics. J Endocrinol Invest1986; 9: 21–5.

    Google Scholar 

  14. Small M, MacRury S, Beastall GH, MacCuish AC. Oestradiol levels in diabetic men with and without a previous myocardial infarction. Q J Med1987; 64: 617–23.

    Google Scholar 

  15. Barrett-Connor E. Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus. Ann Intern Med1992; 117: 807–11.

    Google Scholar 

  16. Pienta KJ, Esper PS. Risk factors for prostate cancer. Ann Intern Med1993; 118: 793–803.

    Google Scholar 

  17. Giovannucci E, Rimm EB, Colditz GA, et al.Aprospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst1993; 85: 1571–9.

    Google Scholar 

  18. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin L, Willett WC. Validity of self-reported waist and hip circumferences in men and women. Epidemiology1990; 1: 466–73.

    Google Scholar 

  19. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol1992; 135: 114–26.

    Google Scholar 

  20. Stampfer MJ, Willett WC, Speizer FE, et al.Test of the National Death Index. Am J Epidemiol1984; 119: 837–9.

    Google Scholar 

  21. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes1979; 28: 1039–57.

    Google Scholar 

  22. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care1994; 17: 961–9.

    Google Scholar 

  23. Colditz GA, Willett WC, Stampfer MJ, et al.Weight as a risk factor for clinical diabetes in women. Am J Epidemiol1990; 132: 501–13.

    Google Scholar 

  24. Rothman KJ. Modern Epidemiology. Boston, MA (USA): Little, Brown, 1986.

    Google Scholar 

  25. Cupples LA, D'Agostino R, Anderson K, Kannel WB. Comparison of baseline and repeated measure covariate techniques in the Framingham Heart Study. Stat Med1988; 7: 205–18.

    Google Scholar 

  26. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst1995; 87: 1767–76.

    Google Scholar 

  27. Gleason DF, Mellinger GT, and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urology1974; 111: 58–64.

    Google Scholar 

  28. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomark Prev1997; 6: 557–63.

    Google Scholar 

  29. Coffey DS. Physiological control of prostatic growth: an overview. In: Prostate Cancer.Geneva, Switzerland: International Union Against Cancer, 1979; UICC Technical Report Series, Vol. 48: 4–23.

    Google Scholar 

  30. Hovenanian MS, Deming CL. The heterologous growth of cancer of the human prostate. Surg Gynecol Obstet1948; 86: 29–35.

    Google Scholar 

  31. Noble RL. The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration. Cancer Res1977; 37: 1929–33.

    Google Scholar 

  32. Pollard M, Luckert PH, Schmidt MA. Induction of prostate adenocarcinomas in Lobund Wistar rats by testosterone. Prostate1982; 4: 563–8.

    Google Scholar 

  33. Robson MC. Cirrhosis and prostatic neoplasms. Geriatrics1966; 21: 150–4.

    Google Scholar 

  34. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. A prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst1996; 88: 1118–26.

    Google Scholar 

  35. Oksanen A. Testicular lesions of streptozotocin diabetic rats. Horm Res1975; 6: 138–44.

    Google Scholar 

  36. Hutson JC, Stocco DM, Campbell GT, Wagoner J. Sertoli cell function in diabetic, insulin-treated diabetic, and semistarved rats. Diabetes1983; 32: 112–6.

    Google Scholar 

  37. Jackson FL, Hutson JC. Altered responses to androgen in diabetic male rats. Diabetes1984; 33: 819–24.

    Google Scholar 

  38. Paz G, Homonnai ZT, Drasnin N, Sofer A, Kaplan R, Kraicer PF. Fertility of the strepozotocin-diabetic male rat. Andrologia1978; 10: 127–36.

    Google Scholar 

  39. Murray FT, Orth J, Gunsalus G, et al.The pituitary-testicular axis in the streptozotocin diabetic male rat: evidence for gonadotroph, Sertoli cell and Leydig cell dysfunction. Int J Androl1981; 4: 265–80.

    Google Scholar 

  40. Peehl DM, Stamey TA. Serum-free growth of adult human prostatic epithelial cells. In Vitro Cell Dev Bio1986; 22: 82–90.

    Google Scholar 

  41. Suikkari AM, Koivisto VA, Rutanen EM, Yki-Jarvinen H, Karonen SL, Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab1988; 66: 266–72.

    Google Scholar 

  42. LeRoith D, Baserga R, Helman L, Roberts CT Jr. Insulinlike growth factors and cancer. Ann Intern Med1995; 122: 54–9.

    Google Scholar 

  43. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab1991; 73: 401–7.

    Google Scholar 

  44. Cohen P, Peehl DM, Graves HCB, Rosenfeld RG. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrin1994; 142: 407–15.

    Google Scholar 

  45. Iwamura M, Sluss PM, Casamento JB, Cockett AT. Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate1993; 22: 243–52.

    Google Scholar 

  46. Horton R, Pasupuletti V, Antonipillai I. Androgen induction of steroid 5 alpha-reductasemay bemediated via insulin-like growth factor-I. Endocrinology1993; 133: 447–51.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital Boston, USA

    Edward Giovannucci, Eric B. Rimm & Walter C. Willett

  2. Department of Nutrition, Harvard School of Public Health Boston, USA

    Meir J. Stampfer

  3. Department of Epidemiology, Harvard School of Public Health Boston, USA

    Graham A. Colditz

Authors
  1. Edward Giovannucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Eric B. Rimm
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Meir J. Stampfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Graham A. Colditz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Walter C. Willett
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giovannucci, E., Rimm, E.B., Stampfer, M.J. et al. Diabetes mellitus and risk of prostate cancer (United States). Cancer Causes Control 9, 3–9 (1998). https://doi.org/10.1023/A:1008822917449

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1008822917449

Search

Navigation